Literature DB >> 20661765

Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view.

David Hallifax1, Joanne A Foster, J Brian Houston.   

Abstract

PURPOSE: To provide a definitive assessment of prediction of in vivo CL (int) from human liver in vitro systems for assessment of typical underprediction.
METHODS: A database of published predictions of clearance from human hepatocytes and liver microsomes was compiled, including only intravenous CL (b). The influence of liver model (well-stirred (WS) or parallel tube (PT)), plasma protein binding and clearance level on the relationship between in vitro and in vivo CL (int) was examined.
RESULTS: Average prediction bias was about 5- and 4-fold for microsomes and hepatocytes, respectively. Reduced bias using the PT model, in preference to the popular WS model, was only marginal across a wide range of clearance with a consequential minor impact on prediction. Increasing underprediction with decreasing fu (b), or increasing CL (int), was found only for hepatocytes, suggesting fundamental in vitro artefacts rather than failure to model potentially unequilibrated binding during rapid extraction.
CONCLUSIONS: In contrast to microsomes, hepatocytes give a disproportionate prediction with increasing clearance suggesting limitations either at the active site, such as cofactor exhaustion, or with intracellular concentration equilibrium, such as rate-limiting cell permeability. A simple log linear empirical relationship can be used to correct hepatocyte predictions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661765     DOI: 10.1007/s11095-010-0218-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.

Authors:  Kiyomi Ito; J Brian Houston
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

2.  Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.

Authors:  Hannah M Jones; J Brian Houston
Journal:  Drug Metab Dispos       Date:  2004-09       Impact factor: 3.922

Review 3.  Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 4.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

5.  Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.

Authors:  R S Obach
Journal:  Drug Metab Dispos       Date:  1997-12       Impact factor: 3.922

Review 6.  The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.

Authors:  André Guillouzo; Anne Corlu; Caroline Aninat; Denise Glaise; Fabrice Morel; Christiane Guguen-Guillouzo
Journal:  Chem Biol Interact       Date:  2006-12-16       Impact factor: 5.192

7.  Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance.

Authors:  Nancy Hakooz; Kiyomi Ito; Helen Rawden; Helen Gill; Lynn Lemmers; Alan R Boobis; Robert J Edwards; David J Carlile; Brian G Lake; J Brian Houston
Journal:  Pharm Res       Date:  2006-02-28       Impact factor: 4.200

Review 8.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

9.  A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.

Authors:  Robert J Riley; D F McGinnity; R P Austin
Journal:  Drug Metab Dispos       Date:  2005-06-02       Impact factor: 3.922

10.  Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells.

Authors:  Dermot F McGinnity; George Zhang; Jane R Kenny; Geraldine A Hamilton; Sara Otmani; Karen R Stams; Suzzette Haney; Patrick Brassil; David M Stresser; Robert J Riley
Journal:  Drug Metab Dispos       Date:  2009-03-23       Impact factor: 3.922

View more
  39 in total

1.  Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.

Authors:  Karelle Ménochet; Kathryn E Kenworthy; J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2012-06-04       Impact factor: 3.922

2.  Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin.

Authors:  Katherine L Gill; J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2012-01-24       Impact factor: 3.922

3.  Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).

Authors:  Christian Maass; Cynthia L Stokes; Linda G Griffith; Murat Cirit
Journal:  Integr Biol (Camb)       Date:  2017-04-18       Impact factor: 2.192

4.  Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction.

Authors:  Bennett Ma; Roy Eisenhandler; Yuhsin Kuo; Paul Rearden; Ying Li; Peter J Manley; Sheri Smith; Karsten Menzel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

Review 5.  Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.

Authors:  Hannah M Jones; Kapil Mayawala; Patrick Poulin
Journal:  AAPS J       Date:  2012-12-27       Impact factor: 4.009

6.  Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.

Authors:  Christine M Bowman; Leslie Z Benet
Journal:  Pharm Res       Date:  2019-05-31       Impact factor: 4.200

7.  An Intuitive Approach for Predicting Potential Human Health Risk with the Tox21 10k Library.

Authors:  Nisha S Sipes; John F Wambaugh; Robert Pearce; Scott S Auerbach; Barbara A Wetmore; Jui-Hua Hsieh; Andrew J Shapiro; Daniel Svoboda; Michael J DeVito; Stephen S Ferguson
Journal:  Environ Sci Technol       Date:  2017-09-06       Impact factor: 9.028

8.  Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies.

Authors:  Nikolaos Tsamandouras; Wen Li Kelly Chen; Collin D Edington; Cynthia L Stokes; Linda G Griffith; Murat Cirit
Journal:  AAPS J       Date:  2017-07-27       Impact factor: 4.009

9.  Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning.

Authors:  Ken Korzekwa; Swati Nagar
Journal:  Pharm Res       Date:  2016-12-13       Impact factor: 4.200

10.  Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research.

Authors:  Na Li; Akshay Badrinarayanan; Kazuya Ishida; Xingwen Li; John Roberts; Shuai Wang; Mike Hayashi; Anshul Gupta
Journal:  AAPS J       Date:  2020-11-16       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.